ALLIANCE N1048

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Gastrointestinal, Rectal

Status:

Closed

A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision (PROSPECT)

Eligible for screening study DCP 001

NCT#01515787

N1048 is permanently closed to new patient accrual effective Friday, December 28, 2018 at 4:30 PM ET.

Leave a Reply